about
Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles BiogenesisA novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosisMechanisms of omega-3 polyunsaturated fatty acids in prostate cancer preventionLipid metabolism in prostate cancerA model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules.Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cellsBone marrow fat: linking adipocyte-induced inflammation with skeletal metastasesSerum levels of arachidonic acid metabolites change during prostate cancer progression.Multivariable analysis of total cholesterol levels in male Swiss Armed Forces conscripts 2006-2012 (N = 174,872).Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer.Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis.Effects of oleic acid on cell proliferation through an integrin-linked kinase signaling pathway in 786-O renal cell carcinoma cells.Fatty acid metabolism: Implications for diet, genetic variation, and disease.A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis.The fat side of prostate cancer.Fatty Acid Synthesis Intermediates Represent Novel Noninvasive Biomarkers of Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate.Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell ViabilityHypoxia induces triglycerides accumulation in prostate cancer cells and extracellular vesicles supporting growth and invasiveness following reoxygenation.Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.Lipid remodelling in human melanoma cells in response to UVA exposure.Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.Lipid catabolism via CPT1 as a therapeutic target for prostate cancer.Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumors via HIF-1α activation.Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism.High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell CarcinomaPlasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk.Differences in prostate cancer grade, stage, and location in radical prostatectomy specimens from United States and Japan.Inhibition of prostate cancer proliferation by Deferiprone.Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity-a pilot study.Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugsLinking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathwaysA novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells
P2860
Q26744233-7C59E03F-D7A1-4EAA-884C-C8C21529EE39Q26774351-93A383A4-F4DB-451A-96A7-F46300DAA94EQ26830150-CFC30E5B-537F-4C01-8851-B26CA9FDB0C2Q27025766-F218541A-0CE2-42A1-A90F-159333E931E2Q30599952-FE32F262-A4D6-4278-8241-39D7EC3FF97AQ33762061-D9F55447-7956-4FA1-B344-0EEF43FB23D4Q34132305-3F79CF44-4BFD-41E0-8FE0-CA767FDA08FBQ34398467-BD6074CE-5853-4B45-B00F-123324E87405Q35926750-FA708243-A9EC-4127-B405-761F15B057F5Q36323141-8E83ABAE-E3B8-4993-8679-447E56482C4AQ36356220-D8F1093A-A597-43ED-B422-C95DAE51C894Q36774751-EA18FA08-1C1D-4ACD-A317-B9357B40DCFAQ37561020-72880951-C1F1-4974-9674-EBF3D8388D6AQ37710823-7137FE9A-B1BB-4A48-ABA9-97F6C52EA9ABQ38096735-F591039E-7115-442C-9A65-CE5095C93E9AQ38375592-152B4079-9A4F-4954-89E1-DB940FC216CCQ38757500-37569265-FB65-4799-81D4-8CDC193C4977Q38862507-C5B8F2EC-22F6-4FE8-A06B-B52721727975Q38895940-654CA28C-F0DD-4309-A78A-6FAA453B20D2Q38901714-1C189C89-7B8B-4D86-90A4-C626F1EE00DFQ38949811-F7E03DB4-FB5E-4CA0-BE36-9D0353F49FDFQ38964675-12B64DA4-FA29-40CC-9C12-84B61D0A4696Q38966211-36C98419-82BF-40C3-9579-FD3A1AFECDB1Q39062508-8CA1A244-55A5-43D7-BDBB-F0877D978C5DQ39139734-EAB1F1C9-1A57-4E11-909D-20952BD225CAQ39428665-CFA091C6-214B-4C1F-A25E-D27924B28957Q41084220-EBDE8F62-3DCA-4390-A8A0-790F4DC5C5F1Q41134388-07A0A92D-89F6-4818-B964-ACEE086A3E59Q42293369-646A36EF-E91A-4234-965C-EBA2F1772E51Q45350463-5695FA37-7753-482A-A050-C8F29F09BBC5Q46687880-1E72785D-7B2A-47DC-8729-94AE751A7DC4Q48150564-709FAC37-C298-4F7E-85EE-9D5B6033D424Q50329520-2CB87B09-1C3B-480D-AE77-8DFB22DD1D50Q50950330-69CAE105-3C95-418F-85FE-8F77D7512AA3Q52564585-EA629EDA-E696-4413-A2E4-B886F5346C1DQ57138111-8ECB94DB-7485-4137-874D-3644A4B1E733Q58562101-864551CE-8CC8-405C-AEB4-7CFCDCCDB3E9Q58801081-A0525ED9-B89E-44EB-BF9B-D964EB4742EC
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lipids and prostate cancer.
@en
type
label
Lipids and prostate cancer.
@en
prefLabel
Lipids and prostate cancer.
@en
P2860
P1476
Lipids and prostate cancer.
@en
P2093
Janel Suburu
Yong Q Chen
P2860
P356
10.1016/J.PROSTAGLANDINS.2012.03.003
P577
2012-04-05T00:00:00Z